Foghorn Therapeutics Director Neil Gallagher Granted 28,000 Stock Options at $4.08

This Form 4 filing reports that Neil Gallagher, a director of Foghorn Therapeutics Inc. (FHTX), was granted 28,000 stock options on June 24, 2026. The options have an exercise price of $4.08 per share and expire on June 23, 2036. According to footnote disclosure, the options vest in full on the first anniversary of the grant date, subject to Gallagher's continued service on the board of directors. The transaction represents an award of derivative securities (stock options) rather than a purchase or sale of common stock. As a director, Gallagher is required to report this equity compensation award under Section 16 of the Securities Exchange Act. The filing was signed on June 25, 2026, by Michael LaCascia as attorney-in-fact for Neil Gallagher.